Asahi Kasei Corp.

AHKSF

$9.56Apr 30, 2021Apr 29, 2026
MaterialsChemicalsCommodity Chemicals$12.96B
MVM
+$0.0M
PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Chart Start
$10.77
2021
Since 2021
-11.3%
vs SPY +70.5%
All-time High
$11.86 · Sep 2021
-19.4% from peak
MVM Rank
#18 of 41
Commodity Chemicals
Reaction Win Rate
55%
11 of 20 events

Asahi Kasei Corp. has returned -11.3% from $10.77 since 2021, trailing SPY's +70.5% over the same period. The stock hit an all-time high of $11.86 in Sep 2021 and is currently 19.4% below that level. Of 20 tracked news events, 55% produced a positive market-adjusted return.

How to use this page
1Company Research Snapshot

Expand to read Wikipedia-sourced background on the company. Click any linked term to explore it inline — no page reload.

2Company Q&A

Common questions answered from real data: performance vs SPY, market cap, profitability, CEO, dividends, and more.

3News & Events

Every dot on the chart is a news event. The return shown is market-adjusted (vs SPY). Green = stock outperformed. Red = underperformed. Dot size = magnitude of reaction.

Show ▼
Company Q&AShow ▼
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2022-08-04-6.2%earningsSeeking AlphaAsahi Kasei; GAAP EPS of 21.50, revenue of 670.44B
2026-04-28-4.9%newsZacks5 Undervalued Price-to-Sales Stocks That Could Deliver Outsized Gains
2022-04-19-2.8%M&ASeeking AlphaAsahi Kasei Medical to acquire US-based biopharmaceutical CDMO Bionova Scientific
2025-04-17+2.2%newsSeeking AlphaAsahi Kasei: Materials Business Could Be Challenged By Macro
2021-08-24+2.0%executiveSeeking AlphaTodd Glogovsky named Chief Operating Officer of Asahi Kasei unit
2024-04-02-1.8%earningsSeeking AlphaAsahi Kasei: Critical Care Should Improve In Margins And Revenues
2025-07-08-1.7%analystMoomooMacquarie Maintains ASAHI KASEI CORP(AHKSF.US) With Buy Rating, Cuts Target Price to $9.53 - Moomoo
2026-04-17-1.0%newsSimply Wall St.Honda Balances Fastport Micromobility Push With Ontario EV Delay
2024-11-04-1.0%newsSeeking AlphaAsahi Kasei: Still Looks Cheap 4 Years On
2023-08-03+1.0%newsSeeking AlphaAsahi Kasei: Not A Bad Proposition
2026-04-20+0.9%newsBusiness WirePeptiDream Announces the Initiation of Phase 1 Clinical Trial by Its Collaboration Partner
2026-04-20+0.9%M&ABusiness WireAsahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy
2026-04-20+0.9%newsGlobeNewswireHealthcare Filtration Markets 2025-2035 with Focus on Biologics Manufacturing Featuring Alfa Laval, Asahi Kasei, Cobetter, Corning, Merck, Pall, Parker Hannifin, Sartorius, Thermo Fisher Scientific
2026-04-20+0.9%M&ASeeking AlphaAsahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy (2026-04-20) - Seeking Alpha
2025-08-19+0.8%earningsSeeking AlphaAsahi Kasei Corporation 2025 Q1 - Results - Earnings Call Presentation
2024-05-28+0.6%newsSeeking AlphaAsahi Kasei To Pay A Fair Price For Calliditas Therapeutics
2024-05-28+0.6%newsSeeking AlphaAsahi Kasei offers to buy Calliditas Therapeutics for $1.1B
2024-05-28+0.6%newsSeeking AlphaAsahi Kasei To Pay A Fair Price For Calliditas Therapeutics (NASDAQ:CALT) - Seeking Alpha
2026-04-22-0.6%newsSeeking AlphaPegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Heart Transplant Patients - Seeking Alpha
2026-04-21-0.4%M&AHospital ManagementAsahi Kasei acquires German company Aicuris
2026-04-30newsZacksBest Value Stocks to Buy for April 30th
2026-04-30newsZacksNew Strong Buy Stocks for April 30th
2026-04-30newsYahoo! Finance CanadaNew Strong Buy Stocks for April 30th - Yahoo! Finance Canada
2026-04-29newsZacksZacks.com featured highlights include Shoe Carnival, Asahi Kasei, Apple Hospitality REIT, Pampa Energia and First American Financial
tickerdossier.comtickerdossier.substack.com